Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.


 

Ongoing Clinical Trials in Advanced Thyroid Cancer: RET Inhibitors (LOXO-292 & BLU-667), NTRK Inhibitors (Larotrectinib, Entrectinib) & IO

0 views
March 18, 2020
Comments 0
Login to view comments. Click here to Login